Please enable JavaScript to continue using this application.

Compare $HUMA vs $IMUX | Chartloom

Compare

$HUMA vs $IMUX

Humacyte Inc · Immunic Inc

HUMA

Humacyte Inc

IMUX

Immunic Inc

Compare $HUMA vs $IMUX

Comparing Humacyte Inc and Immunic Inc

HUMAHumacyte Inc

IMUXImmunic Inc

HUMAHumacyte Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

14.62x

Rev growth (TTM)

159.3%

YTD performance

-58.4%

52W performance

-76.0%

FCF yield

-89.3%

IMUXImmunic Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

40.5%

52W performance

-8.8%

FCF yield

-78.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HUMA

IMUX

Detailed metrics comparison

HUMA

Humacyte Inc

IMUX

Immunic Inc

Market Cap

HUMA$109M

IMUX$112M

Enterprise Value

HUMA$96M

IMUX$-44M

Price

HUMA$0.41

IMUX$8.19

P/E Ratio

HUMAN/A

IMUXN/A

P/S Ratio

HUMA51.53x

IMUX0.00x

EV/Sales

HUMA45.06x

IMUX0.00x

EV/EBITDA

HUMA0.00x

IMUX0.00x

P/B Ratio

HUMA4.63x

IMUX0.85x

P/FCF Ratio

HUMAN/A

IMUXN/A

EV/FCF

HUMA-0.98x

IMUX0.49x

PEG Ratio

HUMAN/A

IMUXN/A

Forward P/E (NTM)

HUMAN/A

IMUXN/A

Forward P/S (NTM)

HUMA14.62x

IMUXN/A

Revenue (TTM)

HUMA$2M

IMUX$0

Revenue Growth (YoY)

HUMA159.3%

IMUXN/A

Forward Rev Growth

HUMA520.3%

IMUX650.4%

Gross Margin (TTM)

HUMA-494.6%

IMUX0.0%

Operating Margin (TTM)

HUMA0.0%

IMUX0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

IMUX0.0%

Net Margin (TTM)

HUMA-4560.8%

IMUX0.0%

FCF Margin (TTM)

HUMA-4599.7%

IMUXN/A

Net Income (TTM)

HUMA$-97M

IMUX$-112M

FCF (TTM)

HUMA$-98M

IMUX$-88M

EPS (TTM)

HUMA-$0.41

IMUX-$2.62

ROE (TTM)

HUMA-51675.0%

IMUX-9567.0%

ROA (TTM)

HUMA-8476.0%

IMUX-10788.0%

ROIC (TTM)

HUMA-9784.0%

IMUX-9567.0%

Cash

HUMA$80M

IMUX$155M

Debt

HUMA$66M

IMUX$0

Net Cash/Debt

HUMA$14M

IMUX$155M

Current Ratio (TTM)

HUMA6.21x

IMUX5.05x

Quick Ratio (TTM)

HUMA5.38x

IMUX5.00x

Debt/Equity (TTM)

HUMA2.12x

IMUX0.00x

Debt/Assets (TTM)

HUMA0.0%

IMUX0.0%

Interest Coverage (TTM)

HUMAN/A

IMUXN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

IMUX0.00x

Beta

HUMA2.76

IMUX1.47

52W Performance

HUMA-76.0%

IMUX-8.8%

YTD Performance

HUMA-58.4%

IMUX40.5%

% from 52W High

HUMA-78.6%

IMUX-53.0%

% from 52W Low

HUMA3.7%

IMUX61.9%

Asset Turnover (TTM)

HUMA0.02x

IMUX0.00x

FCF Yield (TTM)

HUMA-89.3%

IMUX-78.9%

Earnings Yield (TTM)

HUMA-88.5%

IMUX-100.0%

Dividend Yield (TTM)

HUMAN/A

IMUXN/A

Rule of 40

HUMA-4,440.4

IMUX0.0

EV/GP/RG

HUMAN/A

IMUXN/A

Ticker research

View HUMA research View IMUX research

Metric	HUMA Humacyte Inc	IMUX Immunic Inc
Market & Valuation
Market Cap	$109M	$112M
Enterprise Value	$96M	$-44M
Price	$0.41	$8.19
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	0.00x
EV/Sales	45.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	0.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	159.3%	N/A
Forward Rev Growth	520.3%	650.4%
Profitability
Gross Margin (TTM)	-494.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	0.0%
Net Margin (TTM)	-4560.8%	0.0%
FCF Margin (TTM)	-4599.7%	N/A
Net Income (TTM)	$-97M	$-112M
FCF (TTM)	$-98M	$-88M
EPS (TTM)	-$0.41	-$2.62
ROE (TTM)	-51675.0%	-9567.0%
ROA (TTM)	-8476.0%	-10788.0%
ROIC (TTM)	-9784.0%	-9567.0%
Financial Health
Cash	$80M	$155M
Debt	$66M	$0
Net Cash/Debt	$14M	$155M
Current Ratio (TTM)	6.21x	5.05x
Quick Ratio (TTM)	5.38x	5.00x
Debt/Equity (TTM)	2.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	1.47
52W Performance	-76.0%	-8.8%
YTD Performance	-58.4%	40.5%
% from 52W High	-78.6%	-53.0%
% from 52W Low	3.7%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-89.3%	-78.9%
Earnings Yield (TTM)	-88.5%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HUMA research	View IMUX research

Valuation

P/S Ratio

IMUX

0.00x

HUMA

51.53x

EV/FCF

HUMA

-0.98x

IMUX

0.49x

Growth & revenue

Revenue Growth TTM

HUMA

159.3%

Forward Revenue Growth

IMUX

650.4%

HUMA

520.3%

Profitability & performance

Gross Margin

IMUX

0.0%

HUMA

-494.6%

ROE

IMUX

-9567.0%

HUMA

-51675.0%

FCF Yield %

IMUX

-78.9%

HUMA

-89.3%

52-Week Performance

IMUX

-8.8%

HUMA

-76.0%

Detailed metrics comparison

HUMA

Humacyte Inc

IMUX

Immunic Inc

Market Cap

HUMA$109M

IMUX$112M

Enterprise Value

HUMA$96M

IMUX$-44M

Price

HUMA$0.41

IMUX$8.19

P/E Ratio

HUMAN/A

IMUXN/A

P/S Ratio

HUMA51.53x

IMUX0.00x

EV/Sales

HUMA45.06x

IMUX0.00x

EV/EBITDA

HUMA0.00x

IMUX0.00x

P/B Ratio

HUMA4.63x

IMUX0.85x

P/FCF Ratio

HUMAN/A

IMUXN/A

EV/FCF

HUMA-0.98x

IMUX0.49x

PEG Ratio

HUMAN/A

IMUXN/A

Forward P/E (NTM)

HUMAN/A

IMUXN/A

Forward P/S (NTM)

HUMA14.62x

IMUXN/A

Revenue (TTM)

HUMA$2M

IMUX$0

Revenue Growth (YoY)

HUMA159.3%

IMUXN/A

Forward Rev Growth

HUMA520.3%

IMUX650.4%

Gross Margin (TTM)

HUMA-494.6%

IMUX0.0%

Operating Margin (TTM)

HUMA0.0%

IMUX0.0%

EBITDA Margin (TTM)

HUMA-4900.0%

IMUX0.0%

Net Margin (TTM)

HUMA-4560.8%

IMUX0.0%

FCF Margin (TTM)

HUMA-4599.7%

IMUXN/A

Net Income (TTM)

HUMA$-97M

IMUX$-112M

FCF (TTM)

HUMA$-98M

IMUX$-88M

EPS (TTM)

HUMA-$0.41

IMUX-$2.62

ROE (TTM)

HUMA-51675.0%

IMUX-9567.0%

ROA (TTM)

HUMA-8476.0%

IMUX-10788.0%

ROIC (TTM)

HUMA-9784.0%

IMUX-9567.0%

Cash

HUMA$80M

IMUX$155M

Debt

HUMA$66M

IMUX$0

Net Cash/Debt

HUMA$14M

IMUX$155M

Current Ratio (TTM)

HUMA6.21x

IMUX5.05x

Quick Ratio (TTM)

HUMA5.38x

IMUX5.00x

Debt/Equity (TTM)

HUMA2.12x

IMUX0.00x

Debt/Assets (TTM)

HUMA0.0%

IMUX0.0%

Interest Coverage (TTM)

HUMAN/A

IMUXN/A

Net Debt/EBITDA (TTM)

HUMA0.00x

IMUX0.00x

Beta

HUMA2.76

IMUX1.47

52W Performance

HUMA-76.0%

IMUX-8.8%

YTD Performance

HUMA-58.4%

IMUX40.5%

% from 52W High

HUMA-78.6%

IMUX-53.0%

% from 52W Low

HUMA3.7%

IMUX61.9%

Asset Turnover (TTM)

HUMA0.02x

IMUX0.00x

FCF Yield (TTM)

HUMA-89.3%

IMUX-78.9%

Earnings Yield (TTM)

HUMA-88.5%

IMUX-100.0%

Dividend Yield (TTM)

HUMAN/A

IMUXN/A

Rule of 40

HUMA-4,440.4

IMUX0.0

EV/GP/RG

HUMAN/A

IMUXN/A

Ticker research

View HUMA research View IMUX research

Metric	HUMA Humacyte Inc	IMUX Immunic Inc
Market & Valuation
Market Cap	$109M	$112M
Enterprise Value	$96M	$-44M
Price	$0.41	$8.19
P/E Ratio	N/A	N/A
P/S Ratio	51.53x	0.00x
EV/Sales	45.06x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.63x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.98x	0.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	14.62x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	159.3%	N/A
Forward Rev Growth	520.3%	650.4%
Profitability
Gross Margin (TTM)	-494.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-4900.0%	0.0%
Net Margin (TTM)	-4560.8%	0.0%
FCF Margin (TTM)	-4599.7%	N/A
Net Income (TTM)	$-97M	$-112M
FCF (TTM)	$-98M	$-88M
EPS (TTM)	-$0.41	-$2.62
ROE (TTM)	-51675.0%	-9567.0%
ROA (TTM)	-8476.0%	-10788.0%
ROIC (TTM)	-9784.0%	-9567.0%
Financial Health
Cash	$80M	$155M
Debt	$66M	$0
Net Cash/Debt	$14M	$155M
Current Ratio (TTM)	6.21x	5.05x
Quick Ratio (TTM)	5.38x	5.00x
Debt/Equity (TTM)	2.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.76	1.47
52W Performance	-76.0%	-8.8%
YTD Performance	-58.4%	40.5%
% from 52W High	-78.6%	-53.0%
% from 52W Low	3.7%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.02x	0.00x
FCF Yield (TTM)	-89.3%	-78.9%
Earnings Yield (TTM)	-88.5%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-4,440.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HUMA research	View IMUX research